Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia – the role of busulfan pharmacokinetics in determining outcome
Authors:
Open Access
- 5 September 2005
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 36 (10) , 839-845
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- New Strategies in the Treatment of the ThalassemiasAnnual Review of Medicine, 2005
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemiaTransplantation and Cellular Therapy, 2003
- Paediatric allogeneic bone marrow transplantation for homozygous β-thalassaemia, the Dutch experienceBone Marrow Transplantation, 2003
- Allogeneic bone marrow transplantation in the developing world: experience from a center in IndiaBone Marrow Transplantation, 2001
- Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centersTransplantation and Cellular Therapy, 2001
- Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- MARROW TRANSPLANTATION FOR THALASSAEMIAThe Lancet, 1982
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974